Rejuvel Bio-Sciences, Inc.
NUUU
$0.00
$0.000.00%
| 09/30/2015 | 06/30/2015 | ||||
|---|---|---|---|---|---|
| Revenue | 39.61% | -48.72% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 39.61% | -48.72% | |||
| Cost of Revenue | 108.16% | -46.74% | |||
| Gross Profit | 28.43% | -48.86% | |||
| SG&A Expenses | -54.41% | 122.34% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -53.10% | 116.78% | |||
| Operating Income | 58.93% | -171.90% | |||
| Income Before Tax | 47.85% | -156.54% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 47.85% | -156.54% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 47.85% | -156.54% | |||
| EBIT | 58.93% | -171.90% | |||
| EBITDA | 59.15% | -173.62% | |||
| EPS Basic | 48.39% | -153.06% | |||
| Normalized Basic EPS | 48.05% | -156.67% | |||
| EPS Diluted | 19.35% | -153.06% | |||
| Normalized Diluted EPS | 48.05% | -156.67% | |||
| Average Basic Shares Outstanding | 0.16% | 0.95% | |||
| Average Diluted Shares Outstanding | 0.16% | 0.95% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
